Principles of chemotherapy

Clinical Techniques in Small Animal Practice

Volumn 18, Issue 2, 2003, Pages 67-72

  McKnight, Josephine A ^a  

^a ANIMAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; ANTIEMETIC AGENT; ASPARAGINASE; CARBOPLATIN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOLASETRON MESILATE; DOXORUBICIN; FOLIC ACID; FOLINIC ACID; FUROSEMIDE; LOMUSTINE; MELPHALAN; MITOXANTRONE; ONDANSETRON; PREDNISONE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; RAZOXANE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SALAZOSULFAPYRIDINE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ALOPECIA; ANAPHYLAXIS; ANTIBODY PRODUCTION; BLOOD ANALYSIS; BLOOD CELL COUNT; BLOOD VOLUME; BODY WEIGHT; BONE MARROW SUPPRESSION; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CARDIOTOXICITY; COLITIS; DIARRHEA; DNA CROSS LINKING; DNA STRAND BREAKAGE; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG INDICATION; DRUG METABOLISM; DRUG SAFETY; GASTROINTESTINAL TOXICITY; HEART ARRHYTHMIA; HEART MUSCLE BIOPSY; HEART OUTPUT; HEMORRHAGIC CYSTITIS; LIVER TOXICITY; LYMPHATIC LEUKEMIA; LYMPHOCYTOMA; LYMPHOMA; MASTOCYTOMA; MAXIMUM TOLERATED DOSE; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN; PATIENT SELECTION; QUALITY OF LIFE; REVIEW; SARCOMA; THEORETICAL STUDY; THROMBOCYTOPENIA; TREATMENT WITHDRAWAL; URINALYSIS; VOMITING; WALKING; ANIMAL; ANIMAL DISEASE; CLASSIFICATION; NEOPLASM; VETERINARY MEDICINE;

ANIMALS; ANTINEOPLASTIC AGENTS; NEOPLASMS; VETERINARY MEDICINE;

EID: 0038262025     PISSN: 10962867     EISSN: None     Source Type: Journal    
DOI: 10.1053/svms.2003.36617     Document Type: Article

References (61)

1. Morrison WB Cancer in Dogs and Cats: Medical and Surgical Management 1998 Williams & Wilkins Baltimore, MD
2. Chun R, Garrett L, and MacEwen EG Cancer chemotherapy Withrow SJ MacEwen EG Small Animal Clinical Oncology ed 3 2001 Saunders Baltimore, MD 92 118
3. Price GS, and Frazier DL Use of body surface area (BSA)-based dosages to calculate chemotherapeutic drug dose in dogs, I: potential problems with current BSA formulae J Vet Intern Med 12 1998 267 271
4. Page RL, Macy DW, and Thrall DE Unexpected toxicity associated with use of body surface area for dosing melphalan in the dog Cancer Res 48 1988 288 290
5. Ogilvie GK Chemotherapy and the surgery patient: Principles and recent advances Clin Tech Small Animal Pract 13 1998 22 32
6. Ogilvie GK, and Moore AS Managing the Veterinary Cancer Patient: A Practice Manual 1995 Veterinary Learning Systems Philadelphia, PA
7. Stanton ME, and Legendre AM Effects of cyclophosphamide in dogs and cats J Am Vet Med Assoc 188 1986 1319 1322
8. Cotter SM Treatment of lymphoma and leukemia with cyclophosphamide, vincristine and prednisone, II: Treatment of cats J Am Anim Hosp Assoc 19 1983 166 172
9. Moore AS, Cotter SM, and Frimberger AE A comparison of doxorubicin and COP for maintenance of remission in cats with lymphoma J Vet Intern Med 10 1996 372 375
10. Mauldin GN, Matus RE, and Patnaik AK Efficacy and toxicity of doxorubicin and cyclophosphamide used in the treatment of selected malignant tumors in 23 cats J Vet Intern Med 2 1988 60 65
11. Helfand SC, Hamilton TA, and Hungerford LL Comparison of three treatments for transitional cell carcinoma of the bladder in the dog J Am Anim Hosp Assoc 30 1994 270 275
12. Hammer AS, and Couto CG Adjuvant chemotherapy for sarcomas and carcinomas Vet Clin North Am 20 1990 1015 1036
13. Hammer AS, Couto CG, and Filppi J Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma J Vet Intern Med 5 1991 160 166
14. Sorenmo KU, Jeglum KA, and Helfand SC Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide J Vet Intern Med 7 1993 370 376
15. Senior DF, Lawrence DT, and Gunson C Successful treatment of botryoid rhabdomyosarcoma in the bladder of a dog J Am Anim Hosp Assoc 29 1993 386 390
16. Charney SC, Bergman PJ, and Hohenhaus AE Cyclophosphamide-associated sterile hemorrhagic cystitis. A retrospective examination and determination of impact of concurrent furosemide administration Proc Vet Cancer Soc 20 2000 39
17. Keller ET, MacEwen EG, and Rosenthal RC Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma J Vet Intern Med 7 1993 289 295
18. Cotter SM, and Goldstein MA Comparison of two protocols for maintenance of remission in dogs with lymphoma J Am Anim Hosp Assoc 23 1987 495 499
19. Rassnick KM, Moore AS, and Williams LE Treatment of canine mast cell tumors with CCNU (lomustine) J Vet Intern Med 13 1999 601 605
20. Moore AS, London CA, and Wood CA Lomustine (CCNU) for the treatment of resistant lymphoma in dogs J Vet Intern Med 13 1999 395 398
21. Fulton LM, and Steinberg HS Preliminary study of lomustine in the treatment of intracranial masses in dogs following localization by imaging techniques Semin Vet Med Surg 5 1990 241 245
22. Rassnick KM, Gieger TL, and Williams LE Phase I evaluation of CCNU (lomustine) in tumor bearing cats J Vet Intern Med 15 2001 196 199
23. MacEwen EG, Brown NO, and Patnaik AK Cyclic combination chemotherapy for canine lymphosarcoma J Am Vet Med Assoc 178 1987 564 568
24. Mooney SC, Hayes AA, and MacEwen EG Treatment and prognostic factors in lymphoma in cats: 103 cases (1977-1981) J Am Vet Med Assoc 194 1989 696 699
25. Pond EC, and Morrow D Hepatotoxicity associated with methotrexate in a dog J Small Anim Pract 23 1982 659 666
26. Jaffe N, Frei E, and Traggis D Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma N Engl J Med 291 1974 994 997
27. Scott-Moncrieff JCR, Chan TCK, and Samuels ML Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs Cancer Chemother Pharm 29 1991 13 18
28. Ogilvie GK, Reynolds HA, and Richardson RC Phase II evaluation of doxorubicin for treatment of various canine neoplasms J Am Vet Med Assoc 195 1989 1580 1587
29. Berg J, Weinstein MJ, and Springfield DS Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma J Am Vet Med Assoc 206 1995 1555 1560
30. Slawienski MJ, Mauldin GE, and Mauldin GN Malignant colonic neoplasia in cats: 46 cases (1990-1996) J Am Vet Med Assoc 211 1997 878 881
31. Richardson RC, Hahn K, and Knapp D Hematologic changes associated with epirubicin and doxorubicin during the first 21 days following administration Proc Vet Cancer Soc 9 1988 22
32. O'Keefe DA, Sisson DD, and Gelberg HB Systemic toxicity associated with doxorubicin administration in cats J Vet Intern Med 7 1993 309 317
33. Mauldin GE, Fox PR, and Patnaik AK Doxorubicin-induced cardiotoxicosis J Vet Intern Med 6 1992 82 88
34. Imondi AR, Della Torre P, and Mazue G Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats and dogs Cancer Res 56 1996 4200 4204
35. Ogilvie GK, Obradovich JE, and Elmslie RE Efficacy of mitoxantrone against various neoplasms in dogs J Am Vet Med Assoc 198 1991 1618 1621
36. Ogilvie GK, Moore AS, and Obradovich JE Toxicosis and efficacy associated with administration of mitoxantrone to cats with malignant tumors J Am Vet Med Assoc 202 1993 1839 1844
37. Chabner BA, and Myers CE Antitumor antibiotics Devita VT Hellman S Rosenberg SA Cancer: Principles and Practice of Oncology ed 4 1993 Lippincott Trenton, NJ 374 384
38. Straw RC, Withrow SJ, and Richter SL Amputation and cisplatin for treatment of canine osteosarcoma J Vet Intern Med 5 1991 205 210
39. Knapp DW, Richardson RC, and Bonney PL Cisplatin therapy in 41 dogs with malignant tumors J Vet Intern Med 2 1988 41 46
40. Chun R, Knapp DW, and Widmer WR Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993) J Am Vet Med Assoc 209 1996 1588 1591
41. Withrow SJ, Straw RC, and Douple EB Biodegradable polymer with cisplatin for treatment of canine osteosarcoma Proc Vet Cancer Soc 12 1992 68 69
42. Ogilvie GK, Straw RC, and Powers BE Prevalence of nephrotoxicosis associated with a short-term saline solution diuresis protocol for the administration of cisplatin to dogs with malignant tumors: 61 cases (1987-1989) J Am Vet Med Assoc 199 1991 613 616
43. Ogilvie GK, Krawiec DR, and Gelberg HB Short-term diuresis protocol for the administration of cisplatin Am J Vet Res 49 1988 1076 1078
44. Ogilvie GK, Fettman MJ, and Jameson VJ Evaluation of a one hour saline diuresis protocol for the administration of cisplatin to dogs Am J Vet Res 53 1992 1666 1669
45. Ogilvie GK, Straw RG, and Jameson VJ Prevalence of nephrotoxicosis associated with a four hour saline diuresis protocol for the administration of cisplatin to dogs with malignant tumors: 64 cases (1989-1991) J Am Vet Med Assoc 202 1993 1845 1848
46. Knapp DW, Richardson RC, and DeNicola DB Cisplatin toxicity in cats J Vet Intern Med 1 1987 29 35
47. Bergman PJ, MacEven EG, and Kurzman ID Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993) J Vet Intern Med 10 1996 76 81
48. Hahn KA, McEntee MF, and Daniel GB Hematologic and systemic toxicoses associated with carboplatin administration in cats Am J Vet Res 58 1997 677 679
49. Page RL, McEntee MC, and George SL Pharmacokinetic and phase I evaluation of carboplatin in dogs J Vet Intern Med 7 1993 235 240
50. Kisseberth WC, Vail DM, and Jeglum KA Evaluation of carboplatin in tumor bearing cats: a phase I study from the Veterinary Cooperative Oncology Group (VCOG) Proc Vet Cancer Soc 16 1996 21
51. [Clinical Conference] Phillips B Severe, prolonged bone marrow hypoplasia secondary to the use of carboplatin in an azotemic dog J Am Vet Med Assoc 215 1999 1250 1253
52. Calvert CA, Leifer CE, and MacEwen EG Vincristine for treatment of transmissible venereal tumor J Am Vet Med Assoc 181 1982 163 164
53. Myers NC III, Moore AS, and Rand WM Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma J Vet Intern Med 11 1997 333 339
54. Hahn KA, Fletcher CM, and Legendre AM Marked neutropenia in five tumor-bearing cats one week following single-agent vincristine sulfate chemotherapy Vet Clin Pathol 25 1996 121 123
55. Thamm DH, Mauldin EA, and Vail DM Prednisone and vinblastine chemotherapy for canine mast cell tumor--41 cases (1992-1997) J Vet Intern Med 13 1999 491 497
56. Golden DL, and Langston VC Uses of vincristine and vinblastine in dogs and cats J Am Vet Med Assoc 193 1988 1114 1117
57. Valerius KD, Ogilvie GK, and Fettman MJ Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin J Am Vet Med Assoc 214 1999 353 356
58. Chabner BA Miscellaneous agents Devita VJ Hellman S Rosenberg SA Cancer: Principles and Practice of Oncology ed 4 1993 Lippincott Philadelphia, PA 385 389
59. Hansen JF, and Carpenter RH Fatal acute systemic anaphylaxis and hemorrhagic pancreatitis following asparaginase treatment in a dog J Am Anim Hosp Assoc 19 1982 977 980
60. Northrup NC, Rassnick KM, and Cotter SM Risk factors for myelosuppression associated with vincristine/L-asparaginase induction for canine lymphoma Proc Vet Cancer Soc 19 1999 16
61. Distelhorst CW Glucocorticosteroids induce DNA fragmentation in human lymphoid leukemia cells Blood 72 1988 1305 1309